首页 > 市场调查报告书 > 医疗设备

美容整形

市场调查报告书

商品编码

1402087

全球脸部注射剂市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势和预测

Global Facial Injectables Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年12月01日 | 出版商:

Value Market Research | 英文 235 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球脸部注射剂市场需求预计将从 2022 年的 115.9 亿美元达到 2030 年近 320.1 亿美元的市场规模，2023-2030 年研究期间CAGR为 13.54%。

脸部注射是指非手术美容治疗，涉及将物质注射到脸部各个区域，以改善外观、减少皱纹、恢復体积和恢復皮肤纹理。这些注射治疗由合格的医疗专业人员（通常是皮肤科医生或整形外科医生）进行，以解决各种美学问题并实现所需的脸部改善。

市场动态

由于影响消费者偏好和化妆品行业的各种影响因素，脸部注射剂市场呈现成长趋势。老化人口对年轻容貌的渴望推动了对脸部注射剂的需求，为皱纹、细纹和脸部体积损失提供解决方案。非手术治疗因其侵入性极小和减少停机时间而受到欢迎，作为传统手术的替代方案，推动了市场的扩张。注射技术的不断进步、配方的改进和创新的给药方法提高了产品的功效、安全性和耐用性，促进了更广泛的接受。社群媒体和名人的影响极大地影响了消费者的看法，鼓励更多的人考虑透过脸部注射来增强美观。提高意识、减少耻辱感和个人化治疗计划可满足不同的美学需求，使脸部注射更容易获得。经济因素、负担能力选择以及男性对整容手术日益增长的兴趣进一步促进了市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球脸部注射剂市场的每个细分市场进行了包容性评估。脸部注射产业的成长和趋势为本研究提供了整体方法。

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲脸部注射市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。脸部注射剂市场的主要参与者包括 Ispen、Abbvie、Medytox Inc.、Merz GmbH and Co.、KGaA、Revance Therapeutics Inc.、Galderma、Sinclair Pharma。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：脸部注射公司的竞争格局

脸部注射剂市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

公司股份分析
市场集中度
Ispen

公司简介
公司收入
产品
最近的发展

Abbvie

公司简介
公司收入
产品
最近的发展

Medytox Inc.

公司简介
公司收入
产品
最近的发展

Merz GmbH and Co. KGaA

公司简介
公司收入
产品
最近的发展

Revance Therapeutics Inc.

公司简介
公司收入
产品
最近的发展

Galderma

公司简介
公司收入
产品
最近的发展

Sinclair Pharma

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112112985

The global demand for Facial Injectables Market is presumed to reach the market size of nearly USD 32.01 BN by 2030 from USD 11.59 BN in 2022 with a CAGR of 13.54% under the study period 2023 - 2030.

Facial injectables refer to non-surgical cosmetic treatments involving the injection of substances into various facial areas to enhance appearance, reduce wrinkles, restore volume, and rejuvenate skin texture. These injectable treatments are administered by qualified medical professionals, typically dermatologists or plastic surgeons, to address various aesthetic concerns and achieve desired facial enhancements.

MARKET DYNAMICS

The facial injectables market exhibits growth owing to various influential factors shaping consumer preferences and the cosmetic industry. An aging population's desire for youthful looks drives demand for facial injectables, offering solutions for wrinkles, fine lines, and facial volume loss. Non-surgical options' popularity, due to their minimal invasiveness and reduced downtime, fuels the market's expansion as accessible alternatives to traditional surgery. Continual advancements in injectable technologies, improved formulations, and innovative delivery methods enhance product efficacy, safety, and durability, fostering wider acceptance. Social media and celebrity influences significantly impact consumer perceptions, encouraging more individuals to consider facial injectables for aesthetic enhancements. Increased awareness, reduced stigma, and personalized treatment plans cater to diverse aesthetic needs, making facial injectables more accessible. Economic factors, affordability options, and rising male interest in cosmetic procedures further contribute to the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of facial injectables. The growth and trends of facial injectables industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the facial injectables market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Collagen & PMMA Microspheres
Hyaluronic Acid (HA)
Botulinum Toxin Type A
Calcium Hydroxylapatite (CaHA)
Poly-L-Lactic Acid (PLLA)
Others

By Application

Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Lipoatrophy Treatment
Others

By End-Use

MedSpas
Dermatology Clinics
Hospitals

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Facial Injectables market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Facial Injectables market include Ispen, Abbvie, Medytox Inc., Merz GmbH and Co., KGaA, Revance Therapeutics Inc., Galderma, Sinclair Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . FACIAL INJECTABLES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Collagen & PMMA Microspheres Historic and Forecast Sales by Regions
5.5 Hyaluronic Acid (HA) Historic and Forecast Sales by Regions
5.6 Botulinum Toxin Type A Historic and Forecast Sales by Regions
5.7 Calcium Hydroxylapatite (CaHA) Historic and Forecast Sales by Regions
5.8 Poly-L-lactic Acid (PLLA) Historic and Forecast Sales by Regions
5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Facial Line Correction Historic and Forecast Sales by Regions
6.5 Lip Augmentation Historic and Forecast Sales by Regions
6.6 Face Lift Historic and Forecast Sales by Regions
6.7 Acne Scar Treatment Historic and Forecast Sales by Regions
6.8 Lipoatrophy Treatment Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY END-USE

7.1 Overview by End-use
7.2 Historical and Forecast Data
7.3 Analysis by End-use
7.4 MedSpas Historic and Forecast Sales by Regions
7.5 Dermatology Clinics Historic and Forecast Sales by Regions
7.6 Hospitals Historic and Forecast Sales by Regions

8 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE FACIAL INJECTABLES COMPANIES

9.1. Facial Injectables Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF FACIAL INJECTABLES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Ispen
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Abbvie
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Medytox Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Merz GmbH and Co. KGaA
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Revance Therapeutics Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Galderma
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Sinclair Pharma
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments